Colgate-Palmolive (NYSE:CL) Stock Holdings Lifted by Andra AP fonden

Andra AP fonden lifted its stake in shares of Colgate-Palmolive (NYSE:CL) by 20.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 421,085 shares of the company’s stock after acquiring an additional 71,100 shares during the quarter. Colgate-Palmolive accounts for 0.7% of Andra AP fonden’s portfolio, making the stock its 22nd largest holding. Andra AP fonden’s holdings in Colgate-Palmolive were worth $40,862,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of CL. Gryphon Financial Partners LLC acquired a new position in Colgate-Palmolive in the 4th quarter worth approximately $225,000. Principal Securities Inc. acquired a new stake in shares of Colgate-Palmolive in the fourth quarter worth $366,000. Cary Street Partners Investment Advisory LLC grew its holdings in shares of Colgate-Palmolive by 2.4% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 18,590 shares of the company’s stock valued at $1,482,000 after buying an additional 444 shares in the last quarter. QRG Capital Management Inc. raised its position in Colgate-Palmolive by 5.8% during the fourth quarter. QRG Capital Management Inc. now owns 46,633 shares of the company’s stock valued at $3,717,000 after buying an additional 2,540 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in Colgate-Palmolive by 1.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,793,195 shares of the company’s stock worth $222,637,000 after acquiring an additional 30,979 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Sally Massey sold 15,850 shares of the stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the transaction, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The disclosure for this sale can be found here. In the last 90 days, insiders sold 43,490 shares of company stock valued at $4,486,063. Insiders own 0.34% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the topic of several research analyst reports. Sanford C. Bernstein lifted their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research note on Tuesday, July 30th. Jefferies Financial Group lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price objective for the company from $103.00 to $95.00 in a research note on Wednesday, July 24th. Stifel Nicolaus lifted their target price on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, July 22nd. TD Cowen upped their price target on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Tuesday, July 30th. Finally, Evercore ISI increased their price objective on Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a report on Thursday, July 18th. Nine equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $102.63.

Colgate-Palmolive Stock Down 0.7 %

Shares of Colgate-Palmolive stock opened at $107.11 on Tuesday. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $109.30. The stock has a market capitalization of $87.52 billion, a P/E ratio of 33.90, a PEG ratio of 3.78 and a beta of 0.40. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. The stock has a 50 day moving average price of $101.30 and a two-hundred day moving average price of $94.73.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. Colgate-Palmolive’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.77 EPS. Equities analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were paid a $0.50 dividend. The ex-dividend date of this dividend was Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.87%. Colgate-Palmolive’s payout ratio is presently 63.29%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.